Back to stock research

Verified earnings summary

Research updated: Jul 12, 2026, 12:00 AM UTC

MO Q1 2026

Altria reported a strong first quarter supported by smokeable-products income and oral nicotine growth while continuing investment in smoke-free products.

This page provides a source-verified release summary. It does not display a normalized metric table or post-earnings market reaction until those fields are independently verified.

Constructive signals after the release

  • Premium-brand pricing can partly offset secular cigarette volume decline.
  • on! and on! PLUS can broaden Altria's smoke-free portfolio.
  • Cash generation supports dividends and repurchases.

Risks that still need monitoring

  • Cigarette decline

    Combustible volumes face persistent secular and affordability pressure.

  • Nicotine regulation

    FDA actions, taxes and litigation can impair products and economics.

  • NJOY uncertainty

    Product authorization and market-return uncertainty constrain e-vapor progress.

Primary sources

Altria Reports 2026 First-Quarter Results; Reaffirms Full-Year GuidanceAltria Group, Inc. · earningsVerified

Fetched: 7/12/2026, 12:00:00 AM UTC

Published: 4/30/2026, 12:00:00 AM

Open original source
Altria Group, Inc. Investor RelationsAltria Group, Inc. · companyVerified

Fetched: 7/12/2026, 12:00:00 AM UTC

Open original source
Altria Group, Inc. SEC filings and company factsU.S. Securities and Exchange Commission · filingVerified

Fetched: 7/12/2026, 12:00:00 AM UTC

Published: 4/30/2026, 12:00:00 AM

Open original source

Continue research

Open risk researchReturn to full stock research